BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 34756471)

  • 1. The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup.
    Warring SK; Borah B; Moriarty J; Gullerud R; Lemens MA; Destephano C; Sherman ME; Bakkum-Gamez JN
    Gynecol Oncol; 2022 Jan; 164(1):93-97. PubMed ID: 34756471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study.
    van Maldegem LDPR; van der Zande JA; van Werkhoven LA; Ewing-Graham PC; Heemskerk-Gerritsen BAM; van Doorn HC
    Acta Obstet Gynecol Scand; 2024 Jul; 103(7):1283-1291. PubMed ID: 38695570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributing factors related to abnormal uterine bleeding in perimenopausal women: a case-control study.
    Tian Y; Bai B; Wang L; Zhou Z; Tang J
    J Health Popul Nutr; 2024 Apr; 43(1):52. PubMed ID: 38637861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical data of different endometrial pathological types in perimenopausal women with abnormal uterine bleeding.
    Wang L; Quan S; Bai E; Yang X
    Front Oncol; 2024; 14():1370681. PubMed ID: 38487719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Approach: Correlating Ultrasound Imaging with Endometrial Histopathological Analysis in Perimenopausal Women with Heavy Menstrual Bleeding.
    Selvam V; Lakshminarayanan P
    Cureus; 2024 Mar; 16(3):e57201. PubMed ID: 38681284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of transvaginal ultrasonography compared to endometrial biopsy for the etiological diagnosis of abnormal perimenopausal bleeding.
    Nicula R; Diculescu D; Lencu CC; Ciortea R; Bucuri CE; Oltean IA; Trif IA; Mihu D
    Clujul Med; 2017; 90(1):33-39. PubMed ID: 28246495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women.
    Bagepalli Srinivas S; Kubakaddi SS; Polisetti S; Amber S; Guruvare S; Vaman Pai M
    Int J Womens Health; 2020; 12():883-891. PubMed ID: 33149699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new method that facilitates the diagnosis of endometrial cancer: the ratio of endometrial thickness to the full thickness of the uterine wall and subcutaneous adipose tissue measurements.
    Gök S; Atigan A; Gök BC
    Prz Menopauzalny; 2024 Mar; 23(1):25-30. PubMed ID: 38690066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of endometrial modifications in perimenopausal women.
    Nicula R; Costin N
    Clujul Med; 2015; 88(2):101-10. PubMed ID: 26528056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIGO's PALM-COEIN Classification of Abnormal Uterine Bleeding: A Clinico-histopathological Correlation in Indian Setting.
    Mishra D; Sultan S
    J Obstet Gynaecol India; 2017 Apr; 67(2):119-125. PubMed ID: 28405119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic strategies for postmenopausal bleeding.
    Breijer MC; Timmermans A; van Doorn HC; Mol BW; Opmeer BC
    Obstet Gynecol Int; 2010; 2010():850812. PubMed ID: 20169169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of vaginal hysterectomy for endometrial cancer.
    Praiss AM; Huang Y; St Clair CM; Melamed A; Khoury-Collado F; Hou JY; Gockley A; Hillyer GC; Hershman DL; Wright JD
    Gynecol Oncol; 2022 Jan; 164(1):105-112. PubMed ID: 34763940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis.
    Njoku K; Ramchander NC; Wan YL; Barr CE; Crosbie EJ
    Gynecol Oncol; 2022 Jan; 164(1):146-153. PubMed ID: 34802721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001.
    Marth C; Tarnawski R; Tyulyandina A; Pignata S; Gilbert L; Kaen D; Rubio MJ; Frentzas S; Beiner M; Magallanes-Maciel M; Farrelly L; Choi CH; Berger R; Lee C; Vulsteke C; Hasegawa K; Braicu EI; Wu X; McKenzie J; Lee JJ; Makker V
    Int J Gynecol Cancer; 2022 Jan; 32(1):93-100. PubMed ID: 34799418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratified follow-up for endometrial cancer: a move to more personalized cancer care.
    Sarwar A; Van Griethuysen J; Waterhouse J; Dehbi HM; Eminowicz G; McCormack M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1564-1571. PubMed ID: 34795021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: A better prognostic indicator than FIGO staging?
    Ladbury C; Li R; Shiao J; Liu J; Cristea M; Han E; Dellinger T; Lee S; Wang E; Fisher C; Chen YJ; Amini A; Robin T; Glaser S
    Gynecol Oncol; 2022 Jan; 164(1):39-45. PubMed ID: 34794840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis.
    Chae-Kim J; Garg G; Gavrilova-Jordan L; Blake LE; Kim TT; Wu Q; Hayslip CC
    Int J Gynecol Cancer; 2021 Dec; 31(12):1499-1505. PubMed ID: 34785524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-life body mass index and risks of breast, endometrial, and ovarian cancers: a dose-response meta-analysis of prospective studies.
    Byun D; Hong S; Ryu S; Nam Y; Jang H; Cho Y; Keum N; Oh H
    Br J Cancer; 2022 Mar; 126(4):664-672. PubMed ID: 34773099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.
    Manning-Geist BL; Gordhandas SB; Giri DD; Iasonos A; Zhou Q; Girshman J; O'Cearbhaill RE; Zamarin D; Lichtman SM; Sabbatini PJ; Tew WP; Li K; McDonnell AS; Aviki EM; Chi DS; Aghajanian CA; Grisham RN
    Gynecol Oncol; 2022 Jan; 164(1):12-17. PubMed ID: 34763937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel proteomic-based screening method for ovarian cancer using cervicovaginal fluids: A window into the abdomen.
    Rocconi RP; Wilhite AM; Schambeau L; Scalici J; Pannell L; Finan MA
    Gynecol Oncol; 2022 Jan; 164(1):181-186. PubMed ID: 34756750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.